Medical Care

Global Infusion Therapies and Technology Market Outlook, In‑Depth Analysis & Forecast to 2031

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Infusion Therapies and Technology market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Baxter Healthcare
Kelun Group
Fresenius
B. Braun
Ostuka Pharmaceutical
ICU Medical
SSY Group
Shuang Hor
Cisen Pharmaceutical
PiSA Farmacéutica
Huaren Pharmaceutical
Chimin
Beximco Pharma
Albert David
PSI Ltd
Ozon Pharmaceuticals
BML Parenteral Drugs
Segment by Type
Large Volume Intravenous Infusion
Small Volume Intravenous Infusion
Segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Infusion Therapies and Technology study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Infusion Therapies and Technology: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Infusion Therapies and Technology Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Large Volume Intravenous Infusion
1.2.3 Small Volume Intravenous Infusion
1.3 Market Segmentation by Application
1.3.1 Global Infusion Therapies and Technology Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Infusion Therapies and Technology Revenue Estimates and Forecasts 2020-2031
2.2 Global Infusion Therapies and Technology Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Infusion Therapies and Technology Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Infusion Therapies and Technology Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Large Volume Intravenous Infusion Market Size by Players
3.3.2 Small Volume Intravenous Infusion Market Size by Players
3.4 Global Infusion Therapies and Technology Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Infusion Therapies and Technology Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Infusion Therapies and Technology Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Infusion Therapies and Technology Market Size by Type (2020-2031)
6.4 North America Infusion Therapies and Technology Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Infusion Therapies and Technology Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Infusion Therapies and Technology Market Size by Type (2020-2031)
7.4 Europe Infusion Therapies and Technology Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Infusion Therapies and Technology Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Infusion Therapies and Technology Market Size by Type (2020-2031)
8.4 Asia-Pacific Infusion Therapies and Technology Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Infusion Therapies and Technology Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Infusion Therapies and Technology Market Size by Type (2020-2031)
9.4 Central and South America Infusion Therapies and Technology Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Infusion Therapies and Technology Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Infusion Therapies and Technology Market Size by Type (2020-2031)
10.4 Middle East and Africa Infusion Therapies and Technology Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Infusion Therapies and Technology Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Baxter Healthcare
11.1.1 Baxter Healthcare Corporation Information
11.1.2 Baxter Healthcare Business Overview
11.1.3 Baxter Healthcare Infusion Therapies and Technology Product Features and Attributes
11.1.4 Baxter Healthcare Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.1.5 Baxter Healthcare Infusion Therapies and Technology Revenue by Product in 2024
11.1.6 Baxter Healthcare Infusion Therapies and Technology Revenue by Application in 2024
11.1.7 Baxter Healthcare Infusion Therapies and Technology Revenue by Geographic Area in 2024
11.1.8 Baxter Healthcare Infusion Therapies and Technology SWOT Analysis
11.1.9 Baxter Healthcare Recent Developments
11.2 Kelun Group
11.2.1 Kelun Group Corporation Information
11.2.2 Kelun Group Business Overview
11.2.3 Kelun Group Infusion Therapies and Technology Product Features and Attributes
11.2.4 Kelun Group Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.2.5 Kelun Group Infusion Therapies and Technology Revenue by Product in 2024
11.2.6 Kelun Group Infusion Therapies and Technology Revenue by Application in 2024
11.2.7 Kelun Group Infusion Therapies and Technology Revenue by Geographic Area in 2024
11.2.8 Kelun Group Infusion Therapies and Technology SWOT Analysis
11.2.9 Kelun Group Recent Developments
11.3 Fresenius
11.3.1 Fresenius Corporation Information
11.3.2 Fresenius Business Overview
11.3.3 Fresenius Infusion Therapies and Technology Product Features and Attributes
11.3.4 Fresenius Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.3.5 Fresenius Infusion Therapies and Technology Revenue by Product in 2024
11.3.6 Fresenius Infusion Therapies and Technology Revenue by Application in 2024
11.3.7 Fresenius Infusion Therapies and Technology Revenue by Geographic Area in 2024
11.3.8 Fresenius Infusion Therapies and Technology SWOT Analysis
11.3.9 Fresenius Recent Developments
11.4 B. Braun
11.4.1 B. Braun Corporation Information
11.4.2 B. Braun Business Overview
11.4.3 B. Braun Infusion Therapies and Technology Product Features and Attributes
11.4.4 B. Braun Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.4.5 B. Braun Infusion Therapies and Technology Revenue by Product in 2024
11.4.6 B. Braun Infusion Therapies and Technology Revenue by Application in 2024
11.4.7 B. Braun Infusion Therapies and Technology Revenue by Geographic Area in 2024
11.4.8 B. Braun Infusion Therapies and Technology SWOT Analysis
11.4.9 B. Braun Recent Developments
11.5 Ostuka Pharmaceutical
11.5.1 Ostuka Pharmaceutical Corporation Information
11.5.2 Ostuka Pharmaceutical Business Overview
11.5.3 Ostuka Pharmaceutical Infusion Therapies and Technology Product Features and Attributes
11.5.4 Ostuka Pharmaceutical Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.5.5 Ostuka Pharmaceutical Infusion Therapies and Technology Revenue by Product in 2024
11.5.6 Ostuka Pharmaceutical Infusion Therapies and Technology Revenue by Application in 2024
11.5.7 Ostuka Pharmaceutical Infusion Therapies and Technology Revenue by Geographic Area in 2024
11.5.8 Ostuka Pharmaceutical Infusion Therapies and Technology SWOT Analysis
11.5.9 Ostuka Pharmaceutical Recent Developments
11.6 ICU Medical
11.6.1 ICU Medical Corporation Information
11.6.2 ICU Medical Business Overview
11.6.3 ICU Medical Infusion Therapies and Technology Product Features and Attributes
11.6.4 ICU Medical Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.6.5 ICU Medical Recent Developments
11.7 SSY Group
11.7.1 SSY Group Corporation Information
11.7.2 SSY Group Business Overview
11.7.3 SSY Group Infusion Therapies and Technology Product Features and Attributes
11.7.4 SSY Group Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.7.5 SSY Group Recent Developments
11.8 Shuang Hor
11.8.1 Shuang Hor Corporation Information
11.8.2 Shuang Hor Business Overview
11.8.3 Shuang Hor Infusion Therapies and Technology Product Features and Attributes
11.8.4 Shuang Hor Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.8.5 Shuang Hor Recent Developments
11.9 Cisen Pharmaceutical
11.9.1 Cisen Pharmaceutical Corporation Information
11.9.2 Cisen Pharmaceutical Business Overview
11.9.3 Cisen Pharmaceutical Infusion Therapies and Technology Product Features and Attributes
11.9.4 Cisen Pharmaceutical Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.9.5 Cisen Pharmaceutical Recent Developments
11.10 PiSA Farmacéutica
11.10.1 PiSA Farmacéutica Corporation Information
11.10.2 PiSA Farmacéutica Business Overview
11.10.3 PiSA Farmacéutica Infusion Therapies and Technology Product Features and Attributes
11.10.4 PiSA Farmacéutica Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Huaren Pharmaceutical
11.11.1 Huaren Pharmaceutical Corporation Information
11.11.2 Huaren Pharmaceutical Business Overview
11.11.3 Huaren Pharmaceutical Infusion Therapies and Technology Product Features and Attributes
11.11.4 Huaren Pharmaceutical Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.11.5 Huaren Pharmaceutical Recent Developments
11.12 Chimin
11.12.1 Chimin Corporation Information
11.12.2 Chimin Business Overview
11.12.3 Chimin Infusion Therapies and Technology Product Features and Attributes
11.12.4 Chimin Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.12.5 Chimin Recent Developments
11.13 Beximco Pharma
11.13.1 Beximco Pharma Corporation Information
11.13.2 Beximco Pharma Business Overview
11.13.3 Beximco Pharma Infusion Therapies and Technology Product Features and Attributes
11.13.4 Beximco Pharma Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.13.5 Beximco Pharma Recent Developments
11.14 Albert David
11.14.1 Albert David Corporation Information
11.14.2 Albert David Business Overview
11.14.3 Albert David Infusion Therapies and Technology Product Features and Attributes
11.14.4 Albert David Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.14.5 Albert David Recent Developments
11.15 PSI Ltd
11.15.1 PSI Ltd Corporation Information
11.15.2 PSI Ltd Business Overview
11.15.3 PSI Ltd Infusion Therapies and Technology Product Features and Attributes
11.15.4 PSI Ltd Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.15.5 PSI Ltd Recent Developments
11.16 Ozon Pharmaceuticals
11.16.1 Ozon Pharmaceuticals Corporation Information
11.16.2 Ozon Pharmaceuticals Business Overview
11.16.3 Ozon Pharmaceuticals Infusion Therapies and Technology Product Features and Attributes
11.16.4 Ozon Pharmaceuticals Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.16.5 Ozon Pharmaceuticals Recent Developments
11.17 BML Parenteral Drugs
11.17.1 BML Parenteral Drugs Corporation Information
11.17.2 BML Parenteral Drugs Business Overview
11.17.3 BML Parenteral Drugs Infusion Therapies and Technology Product Features and Attributes
11.17.4 BML Parenteral Drugs Infusion Therapies and Technology Revenue and Gross Margin (2020-2025)
11.17.5 BML Parenteral Drugs Recent Developments
12 Infusion Therapies and TechnologyIndustry Chain Analysis
12.1 Infusion Therapies and Technology Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Infusion Therapies and Technology Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Infusion Therapies and Technology Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Infusion Therapies and Technology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Infusion Therapies and Technology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Infusion Therapies and Technology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Infusion Therapies and Technology Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Infusion Therapies and Technology Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Infusion Therapies and Technology Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Infusion Therapies and Technology Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Infusion Therapies and Technology by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infusion Therapies and Technology as of 2024)
Table 11. Global Infusion Therapies and Technology Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Infusion Therapies and Technology Companies Headquarters
Table 13. Global Infusion Therapies and Technology Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Infusion Therapies and Technology Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Infusion Therapies and Technology Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Infusion Therapies and Technology Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Infusion Therapies and Technology Revenue by Application (2026-2031) & (US$ Million)
Table 21. Infusion Therapies and Technology High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Infusion Therapies and Technology Growth Accelerators and Market Barriers
Table 25. North America Infusion Therapies and Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Infusion Therapies and Technology Growth Accelerators and Market Barriers
Table 27. Europe Infusion Therapies and Technology Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Infusion Therapies and Technology Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Infusion Therapies and Technology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Infusion Therapies and Technology Investment Opportunities and Key Challenges
Table 31. Central and South America Infusion Therapies and Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Infusion Therapies and Technology Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Infusion Therapies and Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Baxter Healthcare Corporation Information
Table 35. Baxter Healthcare Description and Major Businesses
Table 36. Baxter Healthcare Product Features and Attributes
Table 37. Baxter Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Baxter Healthcare Revenue Proportion by Product in 2024
Table 39. Baxter Healthcare Revenue Proportion by Application in 2024
Table 40. Baxter Healthcare Revenue Proportion by Geographic Area in 2024
Table 41. Baxter Healthcare Infusion Therapies and Technology SWOT Analysis
Table 42. Baxter Healthcare Recent Developments
Table 43. Kelun Group Corporation Information
Table 44. Kelun Group Description and Major Businesses
Table 45. Kelun Group Product Features and Attributes
Table 46. Kelun Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Kelun Group Revenue Proportion by Product in 2024
Table 48. Kelun Group Revenue Proportion by Application in 2024
Table 49. Kelun Group Revenue Proportion by Geographic Area in 2024
Table 50. Kelun Group Infusion Therapies and Technology SWOT Analysis
Table 51. Kelun Group Recent Developments
Table 52. Fresenius Corporation Information
Table 53. Fresenius Description and Major Businesses
Table 54. Fresenius Product Features and Attributes
Table 55. Fresenius Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Fresenius Revenue Proportion by Product in 2024
Table 57. Fresenius Revenue Proportion by Application in 2024
Table 58. Fresenius Revenue Proportion by Geographic Area in 2024
Table 59. Fresenius Infusion Therapies and Technology SWOT Analysis
Table 60. Fresenius Recent Developments
Table 61. B. Braun Corporation Information
Table 62. B. Braun Description and Major Businesses
Table 63. B. Braun Product Features and Attributes
Table 64. B. Braun Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. B. Braun Revenue Proportion by Product in 2024
Table 66. B. Braun Revenue Proportion by Application in 2024
Table 67. B. Braun Revenue Proportion by Geographic Area in 2024
Table 68. B. Braun Infusion Therapies and Technology SWOT Analysis
Table 69. B. Braun Recent Developments
Table 70. Ostuka Pharmaceutical Corporation Information
Table 71. Ostuka Pharmaceutical Description and Major Businesses
Table 72. Ostuka Pharmaceutical Product Features and Attributes
Table 73. Ostuka Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Ostuka Pharmaceutical Revenue Proportion by Product in 2024
Table 75. Ostuka Pharmaceutical Revenue Proportion by Application in 2024
Table 76. Ostuka Pharmaceutical Revenue Proportion by Geographic Area in 2024
Table 77. Ostuka Pharmaceutical Infusion Therapies and Technology SWOT Analysis
Table 78. Ostuka Pharmaceutical Recent Developments
Table 79. ICU Medical Corporation Information
Table 80. ICU Medical Description and Major Businesses
Table 81. ICU Medical Product Features and Attributes
Table 82. ICU Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. ICU Medical Recent Developments
Table 84. SSY Group Corporation Information
Table 85. SSY Group Description and Major Businesses
Table 86. SSY Group Product Features and Attributes
Table 87. SSY Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. SSY Group Recent Developments
Table 89. Shuang Hor Corporation Information
Table 90. Shuang Hor Description and Major Businesses
Table 91. Shuang Hor Product Features and Attributes
Table 92. Shuang Hor Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Shuang Hor Recent Developments
Table 94. Cisen Pharmaceutical Corporation Information
Table 95. Cisen Pharmaceutical Description and Major Businesses
Table 96. Cisen Pharmaceutical Product Features and Attributes
Table 97. Cisen Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Cisen Pharmaceutical Recent Developments
Table 99. PiSA Farmacéutica Corporation Information
Table 100. PiSA Farmacéutica Description and Major Businesses
Table 101. PiSA Farmacéutica Product Features and Attributes
Table 102. PiSA Farmacéutica Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. PiSA Farmacéutica Recent Developments
Table 104. Huaren Pharmaceutical Corporation Information
Table 105. Huaren Pharmaceutical Description and Major Businesses
Table 106. Huaren Pharmaceutical Product Features and Attributes
Table 107. Huaren Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Huaren Pharmaceutical Recent Developments
Table 109. Chimin Corporation Information
Table 110. Chimin Description and Major Businesses
Table 111. Chimin Product Features and Attributes
Table 112. Chimin Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Chimin Recent Developments
Table 114. Beximco Pharma Corporation Information
Table 115. Beximco Pharma Description and Major Businesses
Table 116. Beximco Pharma Product Features and Attributes
Table 117. Beximco Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Beximco Pharma Recent Developments
Table 119. Albert David Corporation Information
Table 120. Albert David Description and Major Businesses
Table 121. Albert David Product Features and Attributes
Table 122. Albert David Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Albert David Recent Developments
Table 124. PSI Ltd Corporation Information
Table 125. PSI Ltd Description and Major Businesses
Table 126. PSI Ltd Product Features and Attributes
Table 127. PSI Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. PSI Ltd Recent Developments
Table 129. Ozon Pharmaceuticals Corporation Information
Table 130. Ozon Pharmaceuticals Description and Major Businesses
Table 131. Ozon Pharmaceuticals Product Features and Attributes
Table 132. Ozon Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Ozon Pharmaceuticals Recent Developments
Table 134. BML Parenteral Drugs Corporation Information
Table 135. BML Parenteral Drugs Description and Major Businesses
Table 136. BML Parenteral Drugs Product Features and Attributes
Table 137. BML Parenteral Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. BML Parenteral Drugs Recent Developments
Table 139. Raw Materials Key Suppliers
Table 140. Distributors List
Table 141. Market Trends and Market Evolution
Table 142. Market Drivers and Opportunities
Table 143. Market Challenges, Risks, and Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources


List of Figures
Figure 1. Infusion Therapies and Technology Product Picture
Figure 2. Global Infusion Therapies and Technology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Large Volume Intravenous Infusion Product Picture
Figure 4. Small Volume Intravenous Infusion Product Picture
Figure 5. Global Infusion Therapies and Technology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Basic Infusion
Figure 7. Therapeutic Infusion
Figure 8. Nutritious Infusion
Figure 9. Infusion Therapies and Technology Report Years Considered
Figure 10. Global Infusion Therapies and Technology Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 12. Global Infusion Therapies and Technology Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Infusion Therapies and Technology Revenue Market Share by Region (2020-2031)
Figure 14. Global Infusion Therapies and Technology Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Large Volume Intravenous Infusion Revenue Market Share by Player in 2024
Figure 17. Small Volume Intravenous Infusion Revenue Market Share by Player in 2024
Figure 18. Global Infusion Therapies and Technology Revenue Market Share by Type (2020-2031)
Figure 19. Global Infusion Therapies and Technology Revenue Market Share by Application (2020-2031)
Figure 20. North America Infusion Therapies and Technology Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Infusion Therapies and Technology Revenue (US$ Million) in 2024
Figure 22. North America Infusion Therapies and Technology Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Infusion Therapies and Technology Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Infusion Therapies and Technology Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Infusion Therapies and Technology Revenue (US$ Million) in 2024
Figure 29. Europe Infusion Therapies and Technology Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Infusion Therapies and Technology Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 32. France Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Infusion Therapies and Technology Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Infusion Therapies and Technology Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Infusion Therapies and Technology Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Infusion Therapies and Technology Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 44. India Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Infusion Therapies and Technology Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Infusion Therapies and Technology Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Infusion Therapies and Technology Revenue (US$ Million) in 2024
Figure 52. Central and South America Infusion Therapies and Technology Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Infusion Therapies and Technology Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Infusion Therapies and Technology Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Infusion Therapies and Technology Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Infusion Therapies and Technology Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Infusion Therapies and Technology Revenue (US$ Million) in 2024
Figure 58. South America Infusion Therapies and Technology Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Infusion Therapies and Technology Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Infusion Therapies and Technology Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Infusion Therapies and Technology Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Infusion Therapies and Technology Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Infusion Therapies and Technology Revenue (2020-2025) & (US$ Million)
Figure 64. Infusion Therapies and Technology Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies